PCN237 ADOPTION AND UPTAKE OF LIQUID BIOPSY-BASED NSCLC SOMATIC MUTATION TESTING IN THE US CLINICAL SETTING

Autor:	A. Levent, K. Infante, D. Carlow, C. Nash, M. Manger
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Germline mutation business.industry Health Policy Internal medicine Public Health Environmental and Occupational Health medicine Liquid biopsy business
Zdroj:	Value in Health. 22:S101
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.04.358
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::08bbc6a76328aa096176c978711f29d5 https://doi.org/10.1016/j.jval.2019.04.358 Zobrazit plný text záznamu Full Text from ScienceDirect